Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

Overview
Date Founded

2015

Headquarters

20451 Seneca Meadows Parkway, Germantown, MD, 20876-7005, USA

Type of Company

Public

Employees (Worldwide)

192

Industries

Medical Products & Equipment
Electrical Products

Company Description

Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Contact Data
Trying to get in touch with decision makers at Senseonics Holdings, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer

Chief Medical Officer

Vice President & General Manager, US Region

Vice President & General Manager, Global Commercial Operations

Vice President-Engineering, Research & Development

Vice President-Clinical Sciences

Human Resource Manager

Professional

Board of Directors

Partner at Lindsay Goldberg, LLC

General Partner Emeritus & Strategic Adviser at NEA Management Co. LLC

Partner, Healthcare at NEA Management Co. LLC

Founder at Taking Control of Your Diabetes

President & Chief Executive Officer at Senseonics Holdings, Inc.

Chief Financial Officer & Treasurer at Crane & Co., Inc.

Managing Partner at Delphi Ventures, Inc.

Chairman & Chief Executive Officer at TerSera Therapeutics LLC

Paths to Senseonics Holdings, Inc.
Potential Connections via
Relationship Science
You
Senseonics Holdings, Inc.
Owners & Shareholders
Details Hidden

Our firm was founded to help small investors build significant capital over time. Since we believe in owning as many promising stocks as possible, we generally buy on margin.* Borrowing to invest can force liquidations if the market collapses, so we try to balance this exposure by selling short. This ability to seek investments both up and downstream is rarely available to smaller investors. We, however, view it as an effective tool that doubles our clients' dollars at work (it also doubles our commissions), while moderately reducing their exposure to abrupt swings in the market. Our approach is not for the short-term investor. Clients must be able and willing to accept risks. Accounts will experience sharp fluctuations month to month, year to year. It takes a strong stomach to invest with us. Clients entrust decision making for their accounts to us: we buy and sell without asking our clients to authorize in advance each transaction. We are paid commissions for our work

Details Hidden

Polar Asset Management Partners employs a multi-strategy, arbitrage-oriented investment approach. The firm offers a variety of unique investment strategies that can be accessed through commingled funds, managed accounts, and custom portfolios. Their strategies include: Canadian Convertible Arbitrage; US & European Convertible Arbitrage; Fixed Income Arbitrage; Risk Arbitrage; Closed-End Fund Arbitrage; Structured Products Arbitrage; Structured Credit; Canadian Event Driven; US Equity Long/Short; and Canadian Micro-Cap. Polar Asset Management Partners seeks to generate attractive risk-adjusted returns while maintaining a strong emphasis on capital preservation.

Details Hidden

City Financial is an active manager which tailors their investment management services in accordance with each fund's investment strategy across asset classes, geographies and strategies, aiming to achieve risk-adjusted returns with minimal correlation to equity and fixed-income markets.The firm seeks to grow assets organically (through fund performance and net subscriptions) and through strategic acquisitions of pools of assets or companies. They also partner with teams managing portfolios for alternative strategies.City Financial uses a wide range of sources of information and types of analysis, from purely quantitative methods using only price data, to highly qualitative methods using independent analytical work or direct research on the companies or instruments being assessed.Their strategies include long and short stock picking strategies (in equities and corporate and government bonds); themed investment (weather driven; region); fundamental analysis (supply/demand or financial/sectoral); fixed-income strategies and macro/CTA (commodities, government bonds; credit; Fx; CDS).City Financial may also use leverage, such as investing monies secured on margin or taking positions in certain types of derivatives that involve leverage. They may also invest client accounts in certain ETFs that provide leveraged exposure to their underlying indexes.

Recent Transactions
Details Hidden

Senseonics Holdings, Inc. issued . USD Common Stock

Details Hidden

Senseonics Holdings, Inc. issued . USD Common Stock

Details Hidden

Senseonics Holdings, Inc. issued Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Underwriter

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued Common Stock

Advisors & Consultants
Advisor

Former Chief Financial Officer at Senseonics, Inc.

Clients

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Indutrade AB engages in the development, marketing, and sale of components, systems, and services. It operates through the following segments: Benelux, DACH, Finland, Flow Technology (FT), Fluids and Mechanical Solutions (FMS), Industrial Components (IC), Measurement and Sensor Technology (MST), UK, and Others. The Benelux segment offers valves, hydraulic and industrial equipment, measurement technology, and automation products. The DACH segment includes valves, construction material, and hydraulic and industrial equipment. The Finland segment consists of hydraulics and industrial equipment to measurement technology, valves, service, filters, and process technology. The FT segment comprises valves, pipes and pipe systems, measurement technology, pumps, and hydraulics and industrial equipment. The FMS segment provides filters, hydraulics, tools and transmission, industrial springs, valves, water and wastewater fittings, steel profiles, compressors, folding and movable walls, product labelling, and construction plastics. The IC segment offers hydraulics and industrial equipment, chemical technology, and fasteners. The MST segment focuses on the manufacturing industries like electronics, vehicles, and energy. The UK segment provides springs, piston rings, press work, valve channels, pipes, and pipe systems. The Others segment refers to the parent company. The company was founded in 1978 and is headquartered in Kista, Sweden.

Key Stats and Financials As of 2018
Market Capitalization
$457M
Total Enterprise Value
$322M
Earnings Per Share
$-0.6
Revenue
$18.9M
Net Profit
$-94M
EBITDA
$-87.3M
EBITDAMargin
-461.63%
Total Debt
$50.9M
Total Equity
$71.3M
Enterprise Value Sales
17.02x
TEVNet Income
-3.42x
Debt TEV
0.16x
Three Year Compounded Annual Growth Rate Of Revenue
692.47%
Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Medtronic Plc Medical Products & Equipment - Dublin, DU

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Senseonics Holdings, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Senseonics Holdings, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Senseonics Holdings, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/senseonics-holdings-inc-187545956
  • https://relationshipscience.com/organization/senseonics-holdings-inc-187545956